Tissue photosensitizer detection by low-power remittance fluorimetry

Lasers in Medical Science

Volumn 12, Issue 3, 1997, Pages 245-252

  Grahn, M F ^a   De Jode, M L ^a   Dilkes, M G ^a   Ansell, J K ^a   Onwu, D ^a   Maudsley, J ^a   Williams, N S ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Aminolaevulinic acid; Fluorescence; Photochemotherapy; Photofrin ; Spectrometry; Temoporfin (mTHPC)

Indexed keywords

PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; XENON;

ANIMAL TISSUE; BLEACHING; CONFERENCE PAPER; FLUOROPHOTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOUSE; MUSCLE TISSUE; NONHUMAN; PHOTOCHEMOTHERAPY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SPECTROFLUOROMETRY; TUMOR;

EID: 0030868014     PISSN: 02688921     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02765105     Document Type: Conference Paper

References (12)

1. Lipson RC, Baldes EJ, Olsen AM. The use of a derivative of hematoporphyrin in tumour detection. J. Natl Cancer Inst 1961, 26:1-11
2. Grahn MF, Ansell JK. de Jode ML, Maudsley J, Dilkes M, Williams NS. Determination of the optimum druglight interval for PDT. A comparison of animal model and human data. Sixth Biennial Meeting of the IPA. Melbourne, 1996
3. Wang Q, Altermatt JH, Ris HB et al. Determination of 5,10,15,20-tetra-(m-hydroxyphenyl)chlorin in tissues by high performance liquid chromatography. Biomed Chromatog 1993, 7:155-7
4. Bays R, Wagnieres G, Braichotte D, van den Bergh H, Monnier P, Savary J-F. Tissue optics and dosimetry for photodynamic cancer therapy in the oesophagus. In: Jori G, Moan J, Star WM, Katzir A (eds) Proceedings of Photodynamic Therapy of Cancer. SPIE 1994, 2078:Chap 71, pp. 13-26
5. van den Bergh H. Photodynamic therapy and photodetection of early cancer in the upper aerodigestive tract, the tracheobronchial tree, the oesophagus and the urinary bladder. In: Amaldi U, Larsson B (eds) First International Symposium on Hadrontherapy. Como, Italy: Elsevier, 1994:577-621
6. Wilson BC, Jacques SL. Optical reflectance and transmittance of tissues: principles and applications. IEEE J Quantum Electronics 1990, 26:2186-99
7. Jacques, SL. Tissue fluorescence. In: Cortese, DA (ed) Proceedings of the 5th International Photodynamic Association Biennial Meeting. SPIE 1995, 2371:Chap 106, pp. 2-13
8. Braichotte D, Savary JF, Glanzmann T et al. Clinical pharmacokinetic studies of tetra(metahydroxyphenyl)chlorin in squamous cell carcinoma by fluorescence spectroscopy at 2 wavelengths. Int J Cancer 1995, 63:198-204
9. Braichotte DR, Wagnieres GA, Bays R, Monnier P, van den Bergh HE. Clinical pharmacokinetic studies of photofrin by fluorescence spectroscopy in the oral cavity, the esophagus, and the bronchi. Cancer 1995, 75:2768-78
10. Morlet L, Vonarx-Coinsmann V, Lenz P et al. Correlation between meta-tetrahydroxyphenyl)chlorin (m-THPC) biodistribution and photodynamic effects in mice. J Photochem Photobiol B 1995, 28:22-5
11. Alian W, Andersson-Engels S, Svanberg K, Svanberg S. Laser-induced fluorescence studies of mesotetra(hydroxyphenyl)chlorin in malignant and normal tissues in rats. Br J Cancer 1994, 70:830-5
12. Martin A, Tope WD, Grevelink JM et al. Lack of selectivity of protoporphyrin-IX fluorescence for basalcell carcinoma after topical application of 5-aminolevulinic acid - implications for photodynamic treatment. Arch Dermatological Res 1995, 287:665-74